Gilead Sciences, Inc.Gilead Sciences, Inc.Gilead Sciences, Inc.

Gilead Sciences, Inc.

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪150.45 B‬EUR
5.56EUR
‪463.67 M‬EUR
‪27.75 B‬EUR
‪1.24 B‬
Beta (1Y)
0.19
Employees (FY)
‪17.6 K‬
Change (1Y)
−400 −2.22%
Revenue / Employee (1Y)
‪1.58 M‬EUR
Net income / Employee (1Y)
‪26.34 K‬EUR

About Gilead Sciences, Inc.


CEO
Daniel P. O'Day
Website
Headquarters
Foster City
Founded
1987
IPO date
Jan 22, 1992
Identifiers
3
ISIN US3755581036
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Check out other big names from the same industry as GIS.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US375558BF9
Gilead Sciences, Inc. 3.65% 01-MAR-2026
Yield to maturity
6.01%
Maturity date
Mar 1, 2026
GILD5939386
Gilead Sciences, Inc. 5.6% 15-NOV-2064
Yield to maturity
5.68%
Maturity date
Nov 15, 2064
GILD5648609
Gilead Sciences, Inc. 5.55% 15-OCT-2053
Yield to maturity
5.63%
Maturity date
Oct 15, 2053
GILD5939385
Gilead Sciences, Inc. 5.5% 15-NOV-2054
Yield to maturity
5.62%
Maturity date
Nov 15, 2054
US375558BK8
Gilead Sciences, Inc. 4.15% 01-MAR-2047
Yield to maturity
5.58%
Maturity date
Mar 1, 2047
GISE
Gilead Sciences, Inc. 4.75% 01-MAR-2046
Yield to maturity
5.57%
Maturity date
Mar 1, 2046
GILD5050849
Gilead Sciences, Inc. 2.8% 01-OCT-2050
Yield to maturity
5.55%
Maturity date
Oct 1, 2050
GISA
Gilead Sciences, Inc. 4.5% 01-FEB-2045
Yield to maturity
5.53%
Maturity date
Feb 1, 2045
US375558AX11
Gilead Sciences, Inc. 4.8% 01-APR-2044
Yield to maturity
5.52%
Maturity date
Apr 1, 2044
US375558AS26
Gilead Sciences, Inc. 5.65% 01-DEC-2041
Yield to maturity
5.34%
Maturity date
Dec 1, 2041
US375558BS1
Gilead Sciences, Inc. 2.6% 01-OCT-2040
Yield to maturity
5.23%
Maturity date
Oct 1, 2040

See all GIS bonds 

VTI
Vanguard Total Stock Market ETF
Weight
0.23%
Market value
‪4.79 B‬
USD
QQQ
Invesco QQQ Trust Series I
Weight
0.95%
Market value
‪3.86 B‬
USD
VOO
Vanguard S&P 500 ETF
Weight
0.26%
Market value
‪3.86 B‬
USD
IVV
iShares Core S&P 500 ETF
Weight
0.31%
Market value
‪2.34 B‬
USD
SPY
State Street SPDR S&P 500 ETF
Weight
0.30%
Market value
‪2.12 B‬
USD
VTV
Vanguard Value ETF
Weight
0.64%
Market value
‪1.40 B‬
USD
XLV
State Street Health Care Select Sector SPDR ETF
Weight
3.19%
Market value
‪1.30 B‬
USD
IBB
iShares Biotechnology ETF
Weight
9.31%
Market value
‪788.42 M‬
USD
QQQM
Invesco NASDAQ 100 ETF
Weight
0.95%
Market value
‪685.40 M‬
USD
VYM
Vanguard High Dividend Yield Index ETF
Weight
0.72%
Market value
‪612.86 M‬
USD
VHT
Vanguard Health Care ETF
Weight
2.22%
Market value
‪459.55 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of GIS is 124.00 EUR — it has increased by 2.19% in the past 24 hours. Watch Gilead Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Gilead Sciences, Inc. stocks are traded under the ticker GIS.
GIS stock has risen by 5.23% compared to the previous week, the month change is a 19.46% rise, over the last year Gilead Sciences, Inc. has showed a 30.86% increase.
We've gathered analysts' opinions on Gilead Sciences, Inc. future price: according to them, GIS price has a max estimate of 134.88 EUR and a min estimate of 87.37 EUR. Watch GIS chart and read a more detailed Gilead Sciences, Inc. stock forecast: see what analysts think of Gilead Sciences, Inc. and suggest that you do with its stocks.
GIS reached its all-time high on Jan 30, 2026 with the price of 119.86 EUR, and its all-time low was 3.38 EUR and was reached on Jul 11, 2002. View more price dynamics on GIS chart.
See other stocks reaching their highest and lowest prices.
GIS stock is 4.34% volatile and has beta coefficient of 0.19. Track Gilead Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Gilead Sciences, Inc. there?
Today Gilead Sciences, Inc. has the market capitalization of ‪150.58 B‬, it has increased by 1.45% over the last week.
Yes, you can track Gilead Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
Gilead Sciences, Inc. is going to release the next earnings report on Feb 10, 2026. Keep track of upcoming events with our Earnings Calendar.
GIS earnings for the last quarter are 2.10 EUR per share, whereas the estimation was 1.82 EUR resulting in a 15.85% surprise. The estimated earnings for the next quarter are 1.54 EUR per share. See more details about Gilead Sciences, Inc. earnings.
Gilead Sciences, Inc. revenue for the last quarter amounts to ‪6.62 B‬ EUR, despite the estimated figure of ‪6.34 B‬ EUR. In the next quarter, revenue is expected to reach ‪6.55 B‬ EUR.
GIS net income for the last quarter is ‪2.60 B‬ EUR, while the quarter before that showed ‪1.66 B‬ EUR of net income which accounts for 56.32% change. Track more Gilead Sciences, Inc. financial stats to get the full picture.
Yes, GIS dividends are paid quarterly. The last dividend per share was 0.67 EUR. As of today, Dividend Yield (TTM)% is 2.21%. Tracking Gilead Sciences, Inc. dividends might help you take more informed decisions.
Gilead Sciences, Inc. dividend yield was 3.33% in 2024, and payout ratio reached 805.23%. The year before the numbers were 3.70% and 66.62% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 5, 2026, the company has ‪17.6 K‬ employees. See our rating of the largest employees — is Gilead Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Gilead Sciences, Inc. EBITDA is ‪12.02 B‬ EUR, and current EBITDA margin is 46.74%. See more stats in Gilead Sciences, Inc. financial statements.
Like other stocks, GIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gilead Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Gilead Sciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Gilead Sciences, Inc. stock shows the strong buy signal. See more of Gilead Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.